日本大学 · 医学科/医学部

研究キーワードtype 2 diabetes・glycemic variability・CKD progression・GLP-1 receptor agonists・SGLT2 inhibitors・steatotic liver disease

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Pericardial fat pad detected on chest X-ray is closely associated with metabolic dysfunction-associated steatotic liver disease and visceral fat accumulation in patients with type 2 diabetes.2025 · Journal of diabetes and its complications, 2025年10月
• Artifactual hypoglycemia caused by Raynaud's phenomenon: A case report with literature review.2025 · Frontiers in endocrinology, 2025年
• High Glycemic Variability as a Risk Factor for CKD Progression in Type 2 Diabetes with Mild-to-Moderate Kidney Dysfunction.2025 · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2025年11月
• Therapy Combining Glucagon-Like Peptide-1 Receptor Agonist with Sodium-Glucose Cotransporter 2 Inhibitor Suppresses Atherosclerosis in Diabetic ApoE-Deficient Mice.2024 · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2024年09月

• 時計遺伝子Chronoノックアウトマウスに認められた糖代謝障害の解析2025

• 公式プロフィール